TradingView
KhanhC.Hoang
Aug 14, 2022 4:47 PM
trade it to $30
NASDAQ:ALEC
1W
Alector, Inc.
NASDAQ
Description
⋅
Aug 14, 2022 4:47 PM
The safety data is favorable and biomarker/clinical data of AL001 (latozinemab) is supportive of activity in this expanded group of patients. Today's data also suggests the potential for a treatment effect in other TDP pathologies (such as ALS).
Fibonacci
More